A retrospective analysis of VIOXX in Australia: using clinical trial data and linked administrative health data to predict patient groups at risk of an adverse drug event

Authors


Correspondence to:
Dr Margaret Whitstock, PO Box 4264, Melbourne University, Victoria 3052. E-mail: whitstock@iinet.net.au.

No abstract is available for this article.

Ancillary